PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Floppy disks, if you’re older than 30, you likely remember these from school. In the days before CD-Rs, thumb drives, and ...

Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in what would be one of the largest European transactions this year ...

Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...

(Reuters) -Sanofi is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier & Rice (CD&R), a person familiar ...

French stocks traded lower on Monday and the euro was under pressure in the absence of high-tier data releases. ECB policymaker ...

The French finance ministry said in a statement that CD&R was a "serious investment fund" with positive prospects for Opella's development and its plants in France. It added that it would require ...

Presidio, No. 23 on the CRN Solution Provider 500, is being acquired by private equity behemoth Clayton Dubilier and Rice (CD&R) as part of a bid to expand the $6-billion solution provider’s ...

Complete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.

Clayton, Dubilier & Rice With $56 billion in assets, 44-year-old CD&R has invested heavily in energy, construction, and healthcare companies like SmileDirectClub. The New York firm spent more than ...

A representative for Sanofi wasn’t available for comment. Representatives for CD&R and PAI Partners declined to comment. A deal would cap a yearlong effort by Sanofi to split its consumer health ...